| Particulars |
| Company Name |
Glenmark Pharmaceuticals Ltd |
| Face Value |
1 |
| BSE Code |
532296 |
| Year End |
202503 |
| Full Year |
| Equity (Rs in Cr.) |
28.22 |
| B.V. Rs |
868.30 |
| Sales Rs in Cr. |
9,010.54 |
| NP Rs in Cr. |
1,744.30 |
| NP Var% |
22.00 |
| Div% |
250.00 |
| CPS Rs |
69.60 |
| EPS Rs |
61.80 |
| Traded Value(Rs in Lakhs) |
343.02 |
| 52 Week High |
1,840.00 |
| 52 Week Low |
1,273.00 |
| Price BSE |
1,832.00 |
| Price NSE |
1,830.00 |
| Market Capital(Rs in Cr.) |
51,685.08 |
| P/C Ratio |
26.30 |
| P/E Ratio |
29.60 |
| Price Vs.BV |
2.11 |
| Latest Quarter |
| Year End |
202503 |
| Sales Rs in Cr. |
1,909.94 |
| NP Rs in Cr. |
268.56 |
| NP Var % |
-68.00 |
| Trailing Twelve Months |
| Year End |
202503 |
| Sales |
8,273.06 |
| OPM |
22.69 |
| NP |
1,895.02 |
| NP Var% |
22.40 |
| EPS |
61.81 |
| PE |
29.63 |
|